Clinical Trials · NCT00042601

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

CompletedPhase 2Pramlintide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
AstraZeneca
Enrollment
51
Start date
Jul 2002
Locations
1 site, Australia
Primary endpoint
Change in satiety of participants on Pramlintide
View Pramlintide compound reference